Font Size: a A A
Keyword [Nucleos(t)ide analogue]
Result: 1 - 20 | Page: 1 of 2
1. Drug Resistance During Sequential Therapy Of Nucleos(t)ide Analogue In The Treatment Of Chronic Hepatitis B
2. The Impact Of Nucleos(T)ide Analogue Antiviral Therapy On Anxiety And Depression Of Patients With Chronic Hepiatitis B
3. Mutation Analysis Of The HBV Reverse Transcriptase In Nucleos(t)Ide-treatedpatients With Chronic HBV Infection
4. Treatment With Nucleos(t)ide Analogue And Thymosin Alpha-1Versus Nucleos(t)ide Analogue Monotherapy For HBeAg-positive Chronic Hepatitis B: A Meta-analysis
5. The Kinetics Of HBsAg During Long Term Nucleos(t)Ide Analogue Treatment In Chronic Hepatitis B Patients
6. The Expression And Clinical Significance Of Interleukin-21 After Discontinuation Of Nucleos(t)ide Analogue Therapy In Patients With Chronic Hepatitis B
7. Molecular Epidemiology Study Of The Genotypic Mutations Conferring Resistance To Nucleos(t)ide Analogues From Clinical Specimens Of Patients With Hepatitis B
8. Analysis On RtA181T Mutant In HBV Related And Hepatocellular Carcinoma In Patients With Liver Cirrhosis
9. The Prediction Of Virological Relapse And Clinical Relapse After Nucleos(t)ide Analogue Discontinuation:A Prospective Study
10. Cost-effectiveness Analysis Of Nucleos(t)ide Analogue Monotherapies And Initial Combination Treatment For Chinese HBeAg-positive Chronic Hepatitis B Patients
11. Efficacy Of Fuzhenghuayu Capsules Combined With Nucleos(t)ide Analogue In Patients With Hepatitis B Cirrhosis Compensatory Phase
12. Clinical Outcomes Of Nucleos(t)ide Analogue Resistance And Pre-existing Drug Resistance In The Hepatitis B Virus-related Hepatocellular Carcinoma Patients After Radical Resection
13. Cost-effectiveness Analysis Of Nucleos(t)ide Analogue Treatments For Chronic Hepatitis B Patients
14. The Impact Of Nucleos(t)ide Analogues On EGFR In Patients With Chronic HBV Infection
15. Association Of Natural Killer And Hepatitis B Virus-specific T Cells With Virologic Relapse And Liver Damage After Nucleos(t)ide Analogue Cessation
16. Corelation Between CXCL13/CXCR5 Expression And Clinical Relapse After Nucleos(t)ide Analogue Discontinuation In Chronic Hepatitis B Patients
17. Elevated Expression Of Serum Soluble ST2 In Clinical Relapse After Stopping Long-term Nucleos(t)ide Analogue Therapy For Chronic Hepatitis B
18. Analysis Of Variation After Treatment With Nucleos(t) Ide Analogue In Patients With Chronic Hepatitis B
19. Study On The Efficacy And Evolutionary Patterns Of HBV In Patients With Chronic Hepatitis B During Nucleot(s)ide Analog Therapy
20. Long-term Outcomes Of Antiviral Therapy And Relationship Between Changes Of HBsAg Kinetics And Host Adaptive Immunity In Chronic Hepatitis B Patients
  <<First  <Prev  Next>  Last>>  Jump to